UNSPSC 41202038: Lymphocytic choriomeningitis virus serological reagents

In this classification, Lymphocytic choriomeningitis virus serological reagents are devices used in test to identify specific Lymphocytic choriomeningitis virus antibodies in serum. US FDA regulates Lymphocytic choriomeningitis virus serological reagents under 21 CFR 866.3360 and under FDA product code GQK.

UNSPSC 41202038 Lymphocytic choriomeningitis virus serological reagents is a Commodity code that in recent state and local procurement shows almost no alignment with its nominal scope. The recent opportunities tagged under this code are predominantly drug-screening services, HIV rapid-test kits, HIV and syphilis reagents for automated laboratory systems, forensic analysis of biological evidence, clinical diagnostic chemistry testing, and pool maintenance—none of which involve lymphocytic choriomeningitis virus serology. The issuing bodies span state health departments (Illinois Department of Public Health), county criminal justice agencies (Collin County Community Supervision and Corrections Department, Texas Department of Criminal Justice), municipal public health programs (City of Austin), higher education institutions (University of Houston), and county parks and recreation divisions (Collier County). The geographic spread includes Texas, Illinois, and Florida, with activity concentrated in state-level health laboratory procurement and county-level criminal justice drug-testing services.

The most substantial recent opportunity under this code is Collin County's RFP 2026-327 for offender specimen collection and drug testing services, due July 23, 2026, with an estimated contract value of $600,000 over two years with optional renewals through five years total, requiring SAMHSA, Texas DPS, or CAP lab certification and per-test pricing across immunoassay screening and LC/MS/MS or GC/MS confirmation. The Illinois Department of Public Health conducted an emergency sole-source procurement to Abbott Laboratories Inc. (contract value $38,079.50) for HIV and syphilis reagents and maintenance services to support the IDPH Carbondale Laboratory, with award finalized in May 2026. The City of Austin's IFB 9100AAM1023 for rapid HIV Type 1 and Type 2 test kits (due July 17, 2026) and the Illinois Department of Public Health's IFB for hepatitis, HIV, and syphilis four-generation assay screening and instrumentation (due March 16, 2026, with annual test volumes estimated at 13,200 HIV tests and 11,000 syphilis tests) represent typical automated laboratory diagnostics procurement. The code shows little relevant recent activity aligned with its stated commodity name and appears to be a coding mismatch in the underlying procurement records.